LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea · Delayed Price · Currency is KRW 500.00
-59.00 (-10.55%)
Aug 31, 2026, 6:00 PM KST
LabGenomics Revenue
LabGenomics had revenue of 17.93B KRW in the quarter ending March 31, 2026, a decrease of -18.13%. This brings the company's revenue in the last twelve months to 84.19B, down -4.22% year-over-year. In the year 2025, LabGenomics had annual revenue of 88.16B with 2.63% growth.
Revenue (ttm)
84.19B
Revenue Growth
-4.22%
P/S Ratio
0.48
Revenue / Employee
739.43M
Employees
105
Market Cap
37.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 88.16B | 2.26B | 2.63% |
| Dec 31, 2024 | 85.90B | 14.82B | 20.85% |
| Dec 31, 2023 | 71.08B | -73.70B | -50.90% |
| Dec 31, 2022 | 144.77B | -57.63B | -28.47% |
| Dec 31, 2021 | 202.41B | 82.93B | 69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Osang Healthcare Co.,Ltd | 119.38B |
| Ray Co., Ltd. | 119.17B |
| Humasis | 32.87B |
| HASS Corp. | 16.08B |
| Access Bio | 14.94B |
| Sugentech | 9.87B |
| P&S Robotics | 8.55B |